Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in Kentucky

163 recruiting clinical trials across 15 cities in Kentucky (KY). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
163
Total Trials
163
Recruiting Now
15
Cities
20
Conditions

Recruiting Trials in Kentucky

Clinical trial data sourced from ClinicalTrials.gov. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT00682695

Genetic and Environmental Risk Factors for Hemorrhagic Stroke

The purpose of this study is to find risk factors for hemorrhagic stroke.

Sponsor: State University of New York at BuffaloEnrolling: 10007 locations
Stroke
RECRUITINGNCT00919217

Exploratory Study on the Timing of Multiple Sclerosis (MS) Symptoms

The investigators' overall hypothesis is that appearance or worsening of relapsing-remitting multiple sclerosis (RR-MS) symptoms are affected by various factors including stress,...

Sponsor: University of LouisvilleEnrolling: 801 location
Relapsing Remitting Multiple Sclerosis
RECRUITINGPhase 1 / Phase 2NCT01638676

A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients

The main purpose of this study is to evaluate the safety of Vemurafenib in combination with Metformin in melanoma patients. The phase II part of the study will also evaluate the...

Sponsor: University of LouisvilleEnrolling: 551 location
Melanoma
RECRUITINGPhase 3NCT01804686

A Long-term Extension Study of PCI-32765 (Ibrutinib)

The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who...

Sponsor: Janssen Research & Development, LLCEnrolling: 70020 locations
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaMantle Cell Lymphoma+4
RECRUITINGNCT02135705

LOWER: Lomitapide Observational Worldwide Evaluation Registry

This global product exposure registry is a multicentre, long-term, prospective, observational cohort study (exposure registry), designed to evaluate the long term safety and...

Sponsor: Amryt PharmaEnrolling: 30020 locations
Homozygous Familial Hypercholesterolemia
RECRUITINGPhase 2 / Phase 3NCT02205762

LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age \< 18 years).

Sponsor: North American Consortium for HistiocytosisEnrolling: 140020 locations
Langerhans Cell Histiocytosis
RECRUITINGPhase 4NCT02915198

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

This research will help us to learn if the medicine called metformin reduces the risk of death, heart attacks, and/or strokes in Veterans who have pre-diabetes and heart or blood...

Sponsor: VA Office of Research and DevelopmentEnrolling: 741020 locations
Prediabetic StateAtherosclerosisMetformin
RECRUITINGPhase 3NCT03127267

Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

The objective is to compare the efficacy and safety of masitinib in combination with riluzole versus matched placebo in combination with riluzole for the treatment of Amyotrophic...

Sponsor: Ab ScienceEnrolling: 49520 locations
Amyotrophic Lateral Sclerosis
RECRUITINGPhase 2NCT03375307

Testing Olaparib in Patients With Advanced or Metastatic (Cancer That Has Spread) Bladder Cancer and Other...

This phase II trial studies how well olaparib works in treating patients with bladder cancer and other genitourinary tumors with deoxyribonucleic acid (DNA)-repair defects that...

Sponsor: National Cancer Institute (NCI)Enrolling: 6017 locations
Advanced Bladder CarcinomaAdvanced Genitourinary System CarcinomaMetastatic Bladder Carcinoma+3
RECRUITINGPhase 3NCT03401398

Stress Hydrocortisone In Pediatric Septic Shock

SHIPSS is a multi-institutional, prospective, controlled, randomized, double-blinded interventional trial that will examine the potential benefits and risks of adjunctive...

Sponsor: Jerry ZimmermanEnrolling: 50020 locations
Septic Shock
RECRUITINGPhase 1NCT03460977

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and...

The purpose of this study is to learn about the safety and effects of the study medicine (called Mevrometostat) for the possible treatment of Relapsed/ Refractory Small Cell Lung...

Sponsor: PfizerEnrolling: 45320 locations
Metastatic Castration Resistant Prostate Cancer (mCRPC)Small Cell Lung Cancer (SCLC)Follicular Lymphoma (FL)
RECRUITINGPhase 3NCT03592472

A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma...

This is a randomized, Phase 3, double-blind, placebo-controlled study of pazopanib plus abexinostat versus pazopanib plus placebo in patients with locally advanced unresectable or...

Sponsor: Xynomic Pharmaceuticals, INC.Enrolling: 41320 locations
Renal Cell Carcinoma
RECRUITINGPhase 1 / Phase 2NCT03761108

Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

The main purpose of this study is to learn about the safety of linvoseltamab and to find out what is the best dose of linvoseltamab to give to patients with multiple myeloma and...

Sponsor: Regeneron PharmaceuticalsEnrolling: 38720 locations
Multiple Myeloma
RECRUITINGPhase 2NCT03842943

Neoadjuvant Combination Immunotherapy for Stage III Melanoma

Determine safety and efficacy of pre-operative combination immunotherapy with Talimogene Laherparepvec (T-VEC)/Pembrolizumab given prior to complete lymph node dissection in...

Sponsor: University of LouisvilleEnrolling: 281 location
Cutaneous Melanoma
RECRUITINGNCT04071327

Pulmonary Hypertension Association Registry

The PHA Registry (PHAR) is a national study about people who have pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). PHAR collects...

Sponsor: Pulmonary Hypertension Association, Inc.Enrolling: 300020 locations
Pulmonary Arterial HypertensionChronic Thromboembolic Pulmonary HypertensionPulmonary Hypertension
RECRUITINGNCT04165109

Trial-Ready Cohort-Down Syndrome (TRC-DS)

The purpose of the Trial-Ready Cohort - Down Syndrome (TRC-DS) is to enroll 120 healthy adults with Down syndrome (DS), between the ages of 25-55, into a trial ready cohort (TRC),...

Sponsor: University of Southern CaliforniaEnrolling: 55020 locations
Down SyndromeAlzheimer DiseaseDementia
RECRUITINGNCT04174157

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Spinal muscular atrophy (SMA) is a neurogenetic disorder caused by a loss or mutation in the survival motor neuron 1 gene (SMN1) on chromosome 5q13, which leads to reduced SMN...

Sponsor: Novartis PharmaceuticalsEnrolling: 70020 locations
Spinal Muscular Atrophy (SMA)
RECRUITINGNCT04180930

An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample

Given the high prevalence of post-traumatic stress disorder (PTSD) in veterans and active duty military, the focus of this research study is to test the reliability of two new...

Sponsor: U.S. Army Medical Research and Development CommandEnrolling: 9503 locations
Stress Disorders, Post-Traumatic
RECRUITINGNCT04184973

Efficacy and Safety of the CG-100 Intraluminal Bypass Device

A randomized trial to assess the safety and efficacy of CG-100 for reducing stoma creation rate in subjects undergoing mesorectal excision.

Sponsor: Colospan Ltd.Enrolling: 25014 locations
Rectal CancerRectal TumorRectal/Anal
RECRUITINGNCT04202341

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

Long-term, multicenter, multinational, observational, registry of patients with gMG that is designed to collect data on clinical outcomes and safety in patients prescribed Alexion...

Sponsor: Alexion Pharmaceuticals, Inc.Enrolling: 50020 locations
Generalized Myasthenia Gravis
RECRUITINGNCT04208828

IVIG for Drug and Device Refractory Gastrointestinal Auto-Immune Neuropathy

Patients with the symptoms of generalized GI dysmotility, including gastroparesis, are sometimes refractory to available medications, devices and other interventions/ Some of...

Sponsor: University of LouisvilleEnrolling: 4001 location
Gastrointestinal Motility DisorderGastroparesisNeuropathy
RECRUITINGNCT04254185

Clinical Trial for Surgery of the Ulnar Nerve (SUN) at the Elbow

This research is studying two surgical procedures in a large group of people to learn about how well these procedures work as a treatment for ulnar neuropathy at the elbow (UNE)....

Sponsor: University of MichiganEnrolling: 37810 locations
Neuropathy Ulnar
RECRUITINGNCT04278404

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of...

The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children and young adults...

Sponsor: Duke UniversityEnrolling: 500020 locations
Coronavirus Infection (COVID-19)Pulmonary Arterial HypertensionUrinary Tract Infections in Children+22
RECRUITINGPhase 4NCT04373317

Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis

Patients with Parkinson's disease (PD) sometimes experience symptoms affecting their movement, such as slowness, tremor, stiffness, and balance or walking problems. Many patients...

Sponsor: VA Office of Research and DevelopmentEnrolling: 35820 locations
Parkinson's Disease Psychosis
RECRUITINGNCT04421573

Cervical Plexus Hydrodissection With D5W for PTSD

PTSD is a chronic mental health condition that drastically reduces an individual's quality of life Dextrose injection with a small needle has been used for chronic pain patients...

Sponsor: Dr. Dean Reeves ClinicEnrolling: 244 locations
PTSD
RECRUITINGPhase 2 / Phase 3NCT04442022

A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With...

The purpose of this Phase 2/3 study is to evaluate efficacy and safety of the combination of selinexor and R-GDP (SR-GDP) in patients with RR DLBCL who are not intended to receive...

Sponsor: Karyopharm Therapeutics INCEnrolling: 50120 locations
Relapsed/Refractory Diffuse Large B-cell Lymphoma
RECRUITINGNCT04473833

Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer

This is a large, prospective, single-arm cohort study of transvaginal ultrasonographic screening for ovarian cancer in intermediate to high-risk women from Kentucky. Detection of...

Sponsor: John R van NagellEnrolling: 650001 location
Ovarian Cancer
RECRUITINGNCT04496687

International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry

The aim of "iSCAD," the International Spontaneous Coronary Artery Dissection (SCAD) Registry, is to serve as an internationally collaborative, multicenter registry coordinated by...

Sponsor: SCAD AllianceEnrolling: 100020 locations
Spontaneous Coronary Artery Dissection
RECRUITINGPhase 1 / Phase 2NCT04524871

A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With...

This is a Phase Ib/II, open-label, multicenter, randomized umbrella study in participants with advanced liver cancers. The study is designed with the flexibility to open new...

Sponsor: Hoffmann-La RocheEnrolling: 51820 locations
Advanced Liver Cancers
RECRUITINGPhase 2NCT04634552

A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma

The purpose of this study is to evaluate the efficacy and safety of talquetamab in participants with relapsed or refractory multiple myeloma at the recommended Phase 2 dose(s)...

Sponsor: Janssen Research & Development, LLCEnrolling: 51020 locations
Hematological Malignancies

Showing 30 of 163 trials in Kentucky. Search all trials

Browse Trials by State

Frequently Asked Questions

There are currently 163 clinical trials actively recruiting participants in Kentucky. These span all phases from early-stage Phase 1 to late-stage Phase 3 trials, across 20+ conditions.

The top conditions with recruiting trials in Kentucky include Ulcerative Colitis, Pulmonary Hypertension, Ovarian Cancer, Multiple Myeloma, Heart Failure. Each has multiple active trials across research centers in the state.

Major trial sites in Kentucky include Louisville, Lexington, Edgewood, Bowling Green, Fort Thomas. Most large academic medical centers and research hospitals serve as trial sites.

Review the trial listings on this page and check the eligibility criteria — we translate them into plain English. When you find a trial that fits, talk to your doctor about whether it's right for you, then contact the trial team directly using the information on the trial page.

Sources: ClinicalTrials.gov
Last updated:

Trial data sourced from the ClinicalTrials.gov API. Location data reflects registered trial sites. This site does not provide medical advice.